Browse our catalogue of products
224 products displayed
Ref-SKU | Type | Product | Description | ICTV Taxonomy | Virus name | Strain | Isolate | Product Grading | Availability | Product Risk Group | Provider | Cost per Access (Academics) | More info | Add to Cart |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
007V-06180 | Virus | AAV-aCD8 | The AAV8 expresses an anti-CD8 targeting antibody (clone YTS169) allowing long-term depletion of CD8 T cells. The isotope of the depletion antibody is a mouse IgG2a. | Adeno-associated dependoparvovirus B | AAV-aCD8 | Silver | Available within 2 months | RG2 | UNIBAS | 480€ | View all details on this product . . . | Free access available | ||
007V-06173 | Virus | AAV-aCD20 | The AAV8 expresses an anti-CD20 targeting antibody (clone 18B12) allowing long-term depletion of B cells. The isotope of the depletion antibody is a mouse IgG2a. | Adeno-associated dependoparvovirus B | AAV-aCD20 | Silver | Available within 2 months | RG2 | UNIBAS | 480€ | View all details on this product . . . | Free access available | ||
007N-06194 | Nucleic Acid | AAV-aVSVG plasmid | Plasmid encoding the AAV-aVSVG. The AAV-aVSVG expresses a VSVG targeting antibody. | Adeno-associated dependoparvovirus B | AAV-aVSVG | Platinum | In stock | No RG | UNIBAS | 675€ | View all details on this product . . . | Free access available | ||
007N-06193 | Nucleic Acid | AAV-ST2-Fc plasmid | Plasmid encoding the AAV-ST2-Fc. The AAV-ST2-Fc allows blockade of IL-33 signalling. | Adeno-associated dependoparvovirus B | AAV-ST2-Fc | Platinum | In stock | No RG | UNIBAS | 675€ | View all details on this product . . . | Free access available | ||
007N-06192 | Nucleic Acid | AAV-aGr-1 plasmid | Plasmid encoding the AAV-aGr-1. The AAV-aGr-1 allows depletion of neutrophils and myeloid cells. | Adeno-associated dependoparvovirus B | AAV-aGr-1 | Platinum | In stock | No RG | UNIBAS | 675€ | View all details on this product . . . | Free access available | ||
007N-06191 | Nucleic Acid | AAV-aNK1.1 plasmid | Plasmid encoding the AAV-aNK1.1. The AAV-aNK1.1 allows long-term depletion of NK cells. | Adeno-associated dependoparvovirus B | AAV-aNK1.1 | Platinum | In stock | No RG | UNIBAS | 675€ | View all details on this product . . . | Free access available | ||
007N-06190 | Nucleic Acid | AAV-aCD4 plasmid | Plasmid encoding the AAV-aCD4. The AAV-aCD4 allows long-term depletion of CD4 T cells. | Adeno-associated dependoparvovirus B | AAV-aCD4 | Platinum | In stock | No RG | UNIBAS | 675€ | View all details on this product . . . | Free access available | ||
007V-06189 | Virus | AAV-aVSVG | The AAV8 expresses the VI10 antibody targeting the glycoprotein of vesicular stomatitis virus. It can be used as a control for depletion-AAVs. The isotope of the antibody is a mouse IgG2a. | Adeno-associated dependoparvovirus B | AAV-aVSVG | Silver | Available within 2 months | RG2 | UNIBAS | 480€ | View all details on this product . . . | Free access available | ||
007V-06188 | Virus | AAV-ST2-Fc | The AAV8 expresses a soluble ST2 (IL-33 receptor) coupled to the Fc part of an IgG1a antibody, allowing the blockade of IL-33 signalling. | Adeno-associated dependoparvovirus B | AAV-ST2-Fc | Silver | Available within 2 months | RG2 | UNIBAS | 480€ | View all details on this product . . . | Free access available | ||
007V-06187 | Virus | AAV-aGr-1 | The AAV8 expresses an anti-Gr-1 targeting antibody (clone RB6.8C5) allowing the depletion of neutrophils and other myeloid cells. The isotope of the depletion antibody is a mouse IgG2a. | Adeno-associated dependoparvovirus B | AAV-aGr-1 | Silver | Available within 2 months | RG2 | UNIBAS | 480€ | View all details on this product . . . | Free access available | ||
007V-06186 | Virus | AAV-aNK1.1 | The AAV8 expresses an anti-NK1.1 targeting antibody (clone PK136) allowing the long-term depletion of NK cells. The isotope of the depletion antibody is a mouse IgG2a. | Adeno-associated dependoparvovirus B | AAV-aNK1.1 | Silver | Available within 2 months | RG2 | UNIBAS | 480€ | View all details on this product . . . | Free access available | ||
007V-06185 | Virus | AAV-aCD4 | The AAV8 expresses an anti-CD4 targeting antibody (clone YTS191) allowing the long-term depletion of CD4 T cells. The isotope of the depletion antibody is a mouse IgG2a. | Adeno-associated dependoparvovirus B | AAV-aCD4 | Silver | Available within 2 months | RG2 | UNIBAS | 480€ | View all details on this product . . . | Free access available | ||
007N-06174 | Nucleic Acid | AAV-aCD20 plasmid | Plasmid encoding the AAV-aCD20. The AAV-aCD20 allows long-term depletion of B cells. | Adeno-associated dependoparvovirus B | AAV-aCD20 | Platinum | In stock | No RG | UNIBAS | 675€ | View all details on this product . . . | Free access available | ||
007N-06183 | Nucleic Acid | AAV-aCD8 plasmid | Plasmid encoding the AAV-aCD8. The AAV-aCD8 allows long-term depletion of CD8 T cells. | Adeno-associated dependoparvovirus B | AAV-aCD8 | Platinum | In stock | No RG | UNIBAS | 675€ | View all details on this product . . . | Free access available | ||
007V-04003 | Virus | rLCMV-Arm/WE-GP_N63K_Y72F | LCMV Armstrong expressing the glycoprotein of strain WE and carrying a mutation N63K to convert the GP61-80 CD4 epitope to the sequence of the Armstrong/Clone strain and, additionally, carrying a glycoprotein Y72F mutation | Lymphocytic choriomeningitis mammarenavirus | Lymphocytic choriomeningitis virus | Silver | In stock | RG2 | UNIBAS | 480€ | View all details on this product . . . | Free access available | ||
006V-03426 | Virus |
HIV-1_pr-L90M
Antiviral resistant strain |
L90M mutation in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus type 1 | Platinum | Upon request | RG3 | UNIBAS | 2,000€ | View all details on this product . . . | Free access available | ||
007N-06148 | Nucleic Acid | pVSV-GFP | plasmid encoding the VSV antigenome and encoding GFP for producing recombinant VSV | Rhabdoviridae | vesicular stomatitis virus | Platinum | In stock | No RG | UNIBAS | 675€ | View all details on this product . . . | Free access available | ||
007A-05963 | Antibody or Hybridoma | WEN3 | WEN3; LCMV-WE GP neutralizing antibody, monoclonal antibody, mouse IgG2a | Lymphocytic choriomeningitis mammarenavirus | Lymphocytic choriomeningitis virus | Gold | In stock | No RG | UNIBAS | 500€ | View all details on this product . . . | Free access available | ||
006N-03078 | Nucleic Acid |
HIV-1 pNL-_rtD67N
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the reverse transcriptase gene, which can confer drug resistance to specific HIV-1 inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on reverse transcriptase inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-02570 | Nucleic Acid | HIV-1 pNL-BX_pr48V | HIV-1, drug resistant point mutant of protease, reported to be selected in vivo during treatment with protease inhibitors, including saaquinavir. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
006N-03073 | Nucleic Acid |
HIV-1 pNL-BX_prL63P
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with a specific mutation in the protease gene, which has been described as a polymorphic mutation. It is unclear, whether it can confer drug resistance to specific HIV-1 PR inhibitors directly. It has been shown in cell culture that the presence of the 63P change leads to higher "replicative fitness" of the virus. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-03077 | Nucleic Acid |
HIV-1 pNL-BX_prM36V
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-03074 | Nucleic Acid |
HIV-1 pNL-BX_prL90M
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-03081 | Nucleic Acid |
HIV-1 pNL-BX_prL10I
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-03084 | Nucleic Acid |
HIV-1 pNL-BX_pr-L33F
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |